ANRO
Alto Neuroscience, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +4.3% ·
flujo de acciones +9.9% ·
nuevas posiciones netas +4.2%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 56 | +2 | 11.54M | $304.54M | +10 | −8 |
| Q1 2026 | 55 | +7 | 8.39M | $188.63M | +8 | −1 |
| Q4 2025 | 48 | +2 | 8.42M | $149.83M | +3 | −1 |
| Q3 2025 | 15 | +1 | 4.77M | $19.16M | +1 | n/a |
| Q2 2025 | 12 | 0 | 4.77M | $10.50M | +1 | −1 |
| Q1 2025 | 9 | +1 | 3.54M | $7.65M | +2 | −1 |
| Q4 2024 | 8 | +2 | 5.27M | $22.30M | +2 | n/a |
| Q3 2024 | 5 | 0 | 2.33M | $26.66M | +2 | −2 |
| Q2 2024 | 5 | n/a | 1.98M | $21.15M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 1.61M | +20.6% | $28.60M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 2 | The Vanguard Group ✦ (pasivo) | 1.37M | +23.6% | $24.31M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 3 | Franklin Resources Inc | 1.12M | n/a | $19.93M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Millennium Management ✦ | 629.99K | +99.5% | $11.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 607.87K | +65.2% | $10.82M | 0.0% | ▲ Add | 3 | SEC ↗ ×4 |
| 6 | Alkeon Capital Management Llc | 477.10K | n/a | $8.49M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Northern Trust Corp | 474.37K | n/a | $8.44M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Geode Capital Management ✦ (pasivo) | 287.44K | +20.8% | $5.12M | 0.0% | ▲ Add | 7 | SEC ↗ ×2 |
| 9 | Jane Street Group, Llc | 194.04K | n/a | $3.45M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 10 | Marshall Wace ✦ | 193.11K | -76.6% | $3.44M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
| 11 | Goldman Sachs Group ✦ | 156.32K | +73.2% | $2.78M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 12 | Two Sigma Investments ✦ | 140.32K | +20.4% | $2.50M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | State Street Global Advisors ✦ (pasivo) | 130.66K | +26.6% | $2.33M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 124.80K | Nuevo | $2.22M | 0.0% | New | 1 | SEC ↗ |
| 15 | Susquehanna International Group, Llp | 118.16K | n/a | $2.10M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Qube Research & Technologies Ltd | 112.79K | n/a | $2.01M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 97.40K | +28.5% | $1.73M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Stifel Financial Corp | 87.16K | n/a | $1.55M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 69.02K | Nuevo | $1.23M | 0.0% | New | 1 | SEC ↗ ×3 |
| 20 | Morgan Stanley ✦ | 65.58K | +7.5% | $1.17M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 21 | Allianz Asset Management GmbH | 43.00K | n/a | $765,400 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Quantinno Capital Management LP | 35.58K | n/a | $633,306 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Bnp Paribas Financial Markets | 33.23K | n/a | $591,583 | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Dimensional Fund Advisors Lp | 31.18K | n/a | $554,933 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 25 | Barclays Plc | 30.39K | n/a | $540,978 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 26 | T. Rowe Price ✦ | 30.23K | -49.1% | $539,000 | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 27 | Brown Advisory Inc | 25.00K | n/a | $445,000 | 0.0% | n/c | 1 | SEC ↗ |
| 28 | UBS Group AG | 18.49K | n/a | $329,104 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 29 | Charles Schwab Investment… | 17.06K | n/a | $303,739 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Ameriprise Financial Inc | 13.49K | n/a | $240,069 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 12.97K | -65.1% | $230,919 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 32 | Citigroup Inc | 12.57K | n/a | $223,675 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Bank Of Montreal /Can/ | 11.36K | n/a | $202,119 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Balyasny Asset Management L.P. | 11.12K | n/a | $197,936 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Bank Of America Corp /De/ | 11.09K | n/a | $197,437 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 36 | American Century Companies Inc | 10.36K | n/a | $184,408 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 6.37K | -17.0% | $113,457 | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 38 | Group One Trading Llc | 1.41K | n/a | $25,151 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Pnc Financial Services Group, Inc. | 1.31K | n/a | $23,265 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 40 | Federated Hermes, Inc. | 770 | n/a | $13,706 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Wells Fargo & Company/Mn | 765 | n/a | $13,617 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Russell Investments Group, Ltd. | 306 | n/a | $5,447 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Cwm, Llc | 154 | n/a | $3,000 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 146 | Nuevo | $2,599 | 0.0% | New | 1 | SEC ↗ |
| 45 | Us Bancorp \De\ | 113 | n/a | $2,011 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Royal Bank Of Canada | 34 | n/a | $1,000 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Jones Financial Companies Lllp | 33 | n/a | $587 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Optiver Holding B.V. | 20 | n/a | $356 | 0.0% | n/c | 1 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| D. E. Shaw & Co. | $2.22M | 0.0% |
| Wellington Management | $1.23M | 0.0% |
| JPMorgan Chase | $2,599 | 0.0% |
Posición cerrada
| AQR Capital Management | $122,256 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 108 tenedores, 26.83M acciones, $592.78M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 23.17K acc. · $597,290
Officer · 886 acc. · $23,807
Officer · 110.83K acc. · $2.95M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología